Source: International Congress 2019 – Physiology of cystic fibrosis
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Hatziagorou (Thessaloniki, Greece), C. Mantsiou (Thessaloniki, Greece), I. Lialias (Thessaloniki, Greece), E. Kouroukli (Thessaloniki, Greece), L. Nousia (Thessaloniki, Greece), V. Avramidou (Thessaloniki, Greece), J. Tsanakas (Thessaloniki, Greece). Factors affecting progression of lung disease among patients with cystic fibrosis. 329

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017 Year: 2018 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018 Year: 2018 Elucidating progression of early cystic fibrosis lung disease Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017 Year: 2017 Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Relations between the sinonasal development and the lung disease in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 103s Year: 2005 Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020 Year: 2021 Risk factors for progression of cystic fibrosis lung disease from childhood to adulthood Source: Virtual Congress 2020 – Respiratory diseases in children and adults Year: 2020 Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 Factors affecting lung function in adult cystic fibrosis patients after lung transplantation. Source: International Congress 2018 – Evolving approaches to differential diagnosis Year: 2018 Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014 Screening for cystic fibrosis among high risk group patients with chronic lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002 Comorbidities of advanced diseases in patients with cystic fibrosis Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age Year: 2020 Pathophysiology of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 1-13 Year: 2014 How much genotype influences cystic fibrosis associated liver disease? Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006 Endotrophin is related to disease progression in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 Lung function in children with cystic fibrosis liver disease Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Improving airway clearance in cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 169-187 Year: 2014